- Home
- RNAC vs AMCX Comparison
RNAC vs AMCX Comparison
Compare RNAC & AMCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAC
- AMCX
- Stock Information
- Founded
- RNAC 2007
- AMCX 1980
- Country
- RNAC United States
- AMCX United States
- Employees
- RNAC N/A
- AMCX N/A
- Industry
- RNAC Biotechnology: Pharmaceutical Preparations
- AMCX Cable & Other Pay Television Services
- Sector
- RNAC Health Care
- AMCX Telecommunications
- Exchange
- RNAC Nasdaq
- AMCX Nasdaq
- Market Cap
- RNAC 291.7M
- AMCX 275.8M
- IPO Year
- RNAC 2016
- AMCX 2011
- Fundamental
- Price
- RNAC $10.42
- AMCX $6.34
- Analyst Decision
- RNAC Strong Buy
- AMCX Sell
- Analyst Count
- RNAC 7
- AMCX 5
- Target Price
- RNAC $41.00
- AMCX $7.00
- AVG Volume (30 Days)
- RNAC 86.8K
- AMCX 377.3K
- Earning Date
- RNAC 05-08-2025
- AMCX 05-09-2025
- Dividend Yield
- RNAC N/A
- AMCX N/A
- EPS Growth
- RNAC N/A
- AMCX N/A
- EPS
- RNAC N/A
- AMCX N/A
- Revenue
- RNAC $34,173,000.00
- AMCX $2,421,314,000.00
- Revenue This Year
- RNAC N/A
- AMCX N/A
- Revenue Next Year
- RNAC N/A
- AMCX N/A
- P/E Ratio
- RNAC N/A
- AMCX N/A
- Revenue Growth
- RNAC 31.91
- AMCX N/A
- 52 Week Low
- RNAC $8.85
- AMCX $5.41
- 52 Week High
- RNAC $41.87
- AMCX $18.58
- Technical
- Relative Strength Index (RSI)
- RNAC 39.42
- AMCX 53.58
- Support Level
- RNAC $11.18
- AMCX $6.08
- Resistance Level
- RNAC $13.10
- AMCX $6.61
- Average True Range (ATR)
- RNAC 0.90
- AMCX 0.23
- MACD
- RNAC 0.04
- AMCX 0.08
- Stochastic Oscillator
- RNAC 24.61
- AMCX 85.35
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.
About AMCX AMC Networks Inc.
AMC Networks owns several linear pay-TV networks, including AMC, WE tv, BBC America, IFC, and SundanceTV. AMC, its most widely distributed network, reached 60 million pay-TV households in the US at the end of 2024. The firm also had nearly 12.5 million US streaming subscribers, with AMC+ as the flagship streaming platform. With both its linear networks and streaming offerings, the firm caters to specific niche audiences. Over the last 15 years, AMC has shifted its focus to original scripted programming from classic movies. It creates content through AMC Studios and also generates revenue from licensing content. Following an international divestiture at the end of 2023, domestic operations make up nearly 90% of total revenue.